The Lepus europaeus MT-ND4L is a recombinant protein expressed in E. coli with an N-terminal His-tag (6xHis) for purification and detection . This hydrophobic transmembrane protein (98 amino acids) represents a core subunit of mitochondrial Complex I, responsible for electron transfer from NADH to ubiquinone . Its gene (MT-ND4L) overlaps with MT-ND4 in mitochondrial DNA, a unique feature enabling efficient transcription . The recombinant form is optimized for biochemical assays, structural studies, and disease modeling .
MT-ND4L is part of the minimal assembly required for NADH dehydrogenase activity . It participates in:
Electron Transfer: Facilitates NADH-to-ubiquinone electron transport via iron-sulfur clusters and flavin mononucleotide (FMN) .
Proton Pumping: Conformational changes during electron transfer drive H⁺ efflux, contributing to ATP synthesis .
Stability: Forms hydrophobic core of Complex I, anchoring peripheral subunits .
Proper Folding: Hydrophobic nature necessitates denaturation/renaturation steps or detergents for solubility .
Stability: Susceptible to oxidation and aggregation; requires 50% glycerol for storage .
Complex I Assembly Studies:
ELISA and Antibody Development:
Disease Modeling:
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as the electron acceptor.
MT-ND4L (mitochondrially encoded NADH dehydrogenase 4L) is a gene of the mitochondrial genome that codes for NADH-ubiquinone oxidoreductase chain 4L protein. This protein is a subunit of NADH dehydrogenase (ubiquinone), also known as Complex I, which is located in the mitochondrial inner membrane and represents the largest of the five complexes in the electron transport chain .
Functionally, the MT-ND4L protein participates in the first step of the electron transport process during oxidative phosphorylation, specifically in the transfer of electrons from NADH to ubiquinone. This process creates an electrochemical gradient across the inner mitochondrial membrane, which is essential for ATP production, the cell's primary energy source .
Recombinant MT-ND4L is typically produced in expression systems such as E. coli, often with affinity tags (like His-tags) to facilitate purification. While the primary amino acid sequence remains identical to the native protein, several key differences exist:
| Feature | Native MT-ND4L | Recombinant MT-ND4L |
|---|---|---|
| Source | Mitochondrial inner membrane | Expression system (e.g., E. coli) |
| Post-translational modifications | Present as in vivo | May be absent or different |
| Structural context | Embedded within Complex I | Isolated protein or in artificial membrane |
| Affinity tags | Absent | Often present (e.g., His-tag) |
| Stability | Stabilized by Complex I interactions | May require special buffer conditions |
When working with recombinant MT-ND4L, researchers should consider these differences, particularly when interpreting functional assays or structural studies .
For optimal handling of recombinant MT-ND4L:
Storage: Store at -20°C or -80°C for extended storage
Working aliquots: Maintain at 4°C for up to one week
Buffer composition: Use Tris-based buffer with 50% glycerol optimized for protein stability
Avoid: Repeated freeze-thaw cycles which compromise protein integrity
Reconstitution: For lyophilized protein, reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Glycerol addition: Add 5-50% glycerol (final concentration) and aliquot for long-term storage
When preparing working solutions, briefly centrifuge vials prior to opening to bring contents to the bottom of the tube .
| Expression System | Advantages | Limitations | Special Considerations |
|---|---|---|---|
| E. coli | High yield, cost-effective | Lacks post-translational modifications | May require codon optimization |
| Yeast systems | Better folding of membrane proteins | Lower yields than E. coli | Can incorporate some PTMs |
| Insect cells | Good for eukaryotic proteins | More expensive, slower | Better for complex proteins |
| Mammalian cells | Most authentic PTMs | Highest cost, lowest yield | Best for functional studies |
For MT-ND4L specifically, researchers should consider using bacterial strains optimized for membrane protein expression (like C41/C43) and include detergents or lipid nanodiscs to stabilize the hydrophobic regions of the protein .
Multiple complementary methods should be employed:
SDS-PAGE: Verify protein size and assess purity (>90% purity is generally considered acceptable)
Western blotting: Confirm identity using antibodies against MT-ND4L or affinity tags
Mass spectrometry: Verify molecular weight and sequence integrity
Circular dichroism: Assess secondary structure, particularly important for membrane proteins
Activity assays: Measure electron transfer capability within reconstituted systems
Dynamic light scattering: Evaluate homogeneity and detect aggregation
For membrane proteins like MT-ND4L, additional consideration should be given to the detergent environment and lipid composition when assessing functional integrity .
A mutation in MT-ND4L (T10663C or Val65Ala) has been identified in several families with Leber hereditary optic neuropathy (LHON). This mutation changes a single amino acid in the protein, replacing valine with alanine at position 65 .
The mechanisms by which this mutation leads to LHON include:
Disruption of Complex I assembly or stability
Reduced electron transport efficiency
Increased production of reactive oxygen species (ROS)
Compromised ATP production in retinal ganglion cells
Potential interaction with environmental factors and nuclear genetic modifiers
Research methodologies to investigate these mechanisms include:
Cybrid cell studies to isolate the effect of mitochondrial mutations
Oxygen consumption and ATP production measurements
ROS detection assays
Blue native PAGE to assess Complex I assembly
Concurrent mutations in MT-ND4L, such as the 10609T>C and 10663T>C mutations identified in an Arab pedigree, may have synergistic effects on mitochondrial function. These mutations result in non-conservative amino acid changes (Ile47Thr and Val65Ala) in the encoded ND4L protein .
To study these synergistic effects, researchers should:
Create single and double mutants using site-directed mutagenesis
Perform comparative functional assays between wild-type, single mutants, and double mutants
Use molecular dynamics simulations to predict structural changes
Employ biochemical assays to measure electron transport efficiency
Assess ROS production and mitochondrial membrane potential
Conduct pedigree analysis to track co-inheritance patterns
The presence of multiple mutations within a single mitochondrial gene suggests potential epistatic interactions that may exacerbate phenotypes or create novel disease mechanisms .
Recent evidence from the Alzheimer's Disease Sequencing Project (ADSP) reveals a study-wide significant association between Alzheimer's disease (AD) and a rare MT-ND4L variant (rs28709356 C>T; MAF = 0.002; P = 7.3 × 10^-5). Gene-based tests also showed significant association with MT-ND4L (P = 6.71 × 10^-5) .
To investigate this connection, researchers should consider:
Whole exome sequencing with specific pipelines for accurate assembly and variant calling in mitochondrial genomes
Association studies using statistical tests like SCORE and SKAT-O
Expression studies comparing MT-ND4L levels in AD cases vs. controls
Functional assays to assess the impact of AD-associated variants on:
Complex I assembly and activity
ROS production
Neuronal bioenergetics
Synaptic function
Integration of mitochondrial data with nuclear genetic risk factors
This research highlights the importance of considering both mitochondrial variants and nuclear genes related to mitochondrial function (such as TAMM41) when investigating AD pathogenesis .
MT-ND4L sequences can be valuable for phylogenetic analyses due to their relatively conserved nature across species. Researchers investigating evolutionary relationships should:
Obtain MT-ND4L sequences from multiple species of interest
Align sequences using appropriate tools (e.g., Clustal, MUSCLE)
Construct phylogenetic trees using methods such as:
UPGMA (Unweighted Pair Group Method with Arithmetic Mean)
Maximum Likelihood
Bayesian inference
Assess genetic distances between species
Identify conserved versus variable regions that may reflect evolutionary pressures
For example, phylogenetic analysis of MT-ND4L in Khorasan native chickens revealed close relationships with other Asian chicken breeds like Jiangbian, Lvenwu, and Red jungle fowl, with the lowest genetic distance observed between these groups .
When comparing MT-ND4L across mammalian species such as humans, European hare (Lepus europaeus), and domestic dogs (Canis lupus), several differences and similarities emerge:
| Feature | Human MT-ND4L | Lepus europaeus MT-ND4L | Canis lupus MT-ND4L |
|---|---|---|---|
| Length | 98 amino acids | 98 amino acids | 98 amino acids |
| Key conserved regions | Transmembrane domains | Transmembrane domains | Transmembrane domains |
| Variable regions | Loop regions | Loop regions | Loop regions |
| Disease-associated sites | Val65 (LHON) | Corresponding residues may differ | Corresponding residues may differ |
Understanding these differences is crucial for:
Selecting appropriate animal models for disease studies
Interpreting results from cross-species experiments
Designing species-specific antibodies or inhibitors
Identifying functionally critical versus adaptable protein regions
Researchers should conduct careful sequence alignment and homology modeling before extrapolating findings between species .
Investigating interactions between MT-ND4L and other Complex I subunits requires specialized techniques:
Cryo-electron microscopy (cryo-EM):
Provides high-resolution structural information
Can capture different conformational states
Allows visualization of subunit interfaces
Crosslinking mass spectrometry (XL-MS):
Identifies specific amino acid contacts between subunits
Can detect transient interactions
Complementary to cryo-EM data
FRET (Förster Resonance Energy Transfer):
Measures distances between labeled subunits
Can be performed in living cells
Detects conformational changes during catalysis
Co-immunoprecipitation with specific antibodies:
Identifies stable protein-protein interactions
Can be coupled with mass spectrometry for identification
Genetic approaches:
Site-directed mutagenesis to disrupt specific interfaces
Suppressor mutation analysis to identify compensatory changes
These methods can reveal how mutations in MT-ND4L affect its integration into Complex I and subsequent functional consequences .
Recombinant MT-ND4L offers several potential therapeutic applications for mitochondrial diseases:
Gene therapy approaches:
Use of AAV (adeno-associated virus) vectors for delivery of wild-type MT-ND4L
Development of allotopic expression systems (expressing mitochondrial genes from the nucleus)
CRISPR-based mitochondrial DNA editing techniques
Drug development:
High-throughput screening platforms using recombinant MT-ND4L
Structure-based drug design targeting specific mutations
Identification of compounds that stabilize mutant MT-ND4L function
Biomarker development:
Generation of antibodies against wild-type and mutant MT-ND4L forms
Monitoring therapy effectiveness through conformational antibodies
Protein replacement strategies:
Development of cell-penetrating peptide tags for MT-ND4L delivery
Liposome-based delivery systems for membrane proteins
These approaches require careful consideration of the unique challenges associated with targeting mitochondrial proteins, including double membrane penetration and proper protein folding and integration .
Several experimental models offer unique advantages for studying MT-ND4L mutations:
| Model System | Advantages | Limitations | Best Applications |
|---|---|---|---|
| Transmitochondrial cybrid cells | Isolate mtDNA effects | Limited to cell types | Biochemical studies, drug screening |
| Drosophila models | Fast generation time, genetic tools | Evolutionary distance from mammals | High-throughput genetic studies |
| Mouse models | Mammalian physiology | Difficulty introducing mtDNA mutations | In vivo pathophysiology |
| Patient-derived iPSCs | Human genetic background | Variability between lines | Disease modeling, personalized medicine |
| Yeast | Easily manipulated mtDNA | Evolutionary distance | Basic functional studies |
For comprehensive investigation of MT-ND4L mutations, researchers should:
Begin with biochemical characterization in cybrid cells
Confirm findings in patient-derived tissues when available
Develop animal models for in vivo studies
Use multiple models to validate findings across systems
Each model system provides complementary insights into mutation effects across different biological contexts .